|
|
 |
|
Viewing report
|
|
|
|
Antitargets: Prediction and Prevention of Drug Side Effects
John Wiley and Sons Ltd, Jan 2008, Pages: 504
This practice-oriented handbook surveys current knowledge on the prediction and prevention of adverse drug reactions related to off-target activity of small molecule drugs. It is unique in collating the current approaches into a single source, and includes several highly instructive case studies that may be used as guidelines on how to improve drug development projects.
With its large section on ADME-related effects, this is key knowledge for every drug developer.
Author Information
Roy Vaz is the head of investigative pharmacokinetics at the Bridgewater, NJ (USA) location of Sanofi-Aventis Pharmaceuticals. He received his Ph.D. in Organic Chemistry from the University of Florida, Gainesville (USA), after graduating from the Indian Institute of Technology in Mumbai (India). Prior to his present appointment, he has worked with Bristol-Myers-Squibb and Tripos. He is a specialist on the prediction and modeling of cytochrome-mediated drug metabolism.
Thomas Klabunde obtained his PhD in chemistry from the University of Münster (Germany). After a postdoctoral fellowship at the Texas A&M University, he was appointed Assistant Professor at the Institute for Bioscience and Technology in Houston (USA). Later on, he joined the pharmaceutical research of Sanofi-Aventis in Frankfurt (Germany), where he is currently a group leader. His main interest lies with drug design approaches for G protein-coupled receptors, notably in the areas of lead finding and chemogenomics.
Customers who bought this item also bought
Herg: Technology and Market Analysis
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad
Repositioning ADME Studies: A Strategy to Reduce Drug Attrition
Nuclear Receptors in Drug Metabolism
World ADME/Tox in Drug Development Markets
Human Drug Metabolism: An Introduction
Structure-Guided Drug Design: Rediscovering the Importance of Drug Structure for Drug Discovery
Genomics in Drug Discovery and Development
Hit and Lead Profiling: Identification and Optimization of Drug-like Molecules
The Art of Drug Synthesis
Organic and Medicinal Chemistry in Drug Discovery: Pharma's Intelligent Design
Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates
|
|
|
|
